Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2023 Dec 17:2023.11.14.566855.
doi: 10.1101/2023.11.14.566855.

Dorsal Motor Vagal Neurons Can Elicit Bradycardia and Reduce Anxiety-Like Behavior

Affiliations

Dorsal Motor Vagal Neurons Can Elicit Bradycardia and Reduce Anxiety-Like Behavior

Misty M Strain et al. bioRxiv. .

Update in

Abstract

Cardiovagal neurons (CVNs) innervate cardiac ganglia through the vagus nerve to control cardiac function. Although the cardioinhibitory role of CVNs in nucleus ambiguus (CVNNA) is well established, the nature and functionality of CVNs in dorsal motor nucleus of the vagus (CVNDMV) is less clear. We therefore aimed to characterize CVNDMV anatomically, physiologically, and functionally. Optogenetically activating cholinergic DMV neurons resulted in robust bradycardia through peripheral muscarinic (parasympathetic) and nicotinic (ganglionic) acetylcholine receptors, but not beta-1-adrenergic (sympathetic) receptors. Retrograde tracing from the cardiac fat pad labeled CVNNA and CVNDMV through the vagus nerve. Using whole cell patch clamp, CVNDMV demonstrated greater hyperexcitability and spontaneous action potential firing ex vivo despite similar resting membrane potentials, compared to CVNNA. Chemogenetically activating DMV also caused significant bradycardia with a correlated reduction in anxiety-like behavior. Thus, DMV contains uniquely hyperexcitable CVNs capable of cardioinhibition and robust anxiolysis.

Keywords: autonomic regulation; parasympathetic nervous system.

PubMed Disclaimer

Conflict of interest statement

DECLARATION OF INTEREST Authors declare no competing interest.

Figures

Figure 1:
Figure 1:
Optogenetic stimulation of DMV elicits bradycardia in male and female mice. Genetic crossbreeding paradigm used to generate transgenic mice harboring loxP-flanked ChR2 in Chat-positive motor neurons (A). Photostimulation-evoked action potentials from DMV motor neurons pace to 20 Hz stimulation (B). Representative diagram illustrating confirmed locations of optogenetic probes (C). Representative images of DMV (top) and NA (bottom) stained for the neuronal activation marker, c-Fos (middle panel; red) and GFP (left panel; green) immunoreactivity confirming c-Fos activation in DMV, but not NA, after DMV photostimulation (D). Schematic illustrating time course of optogenetic studies in awake mice (E). Representative trace (F) and mean HR (G) showing optogenetic stimulation of DMV produced a bradycardia in mice expressing Chatcre;ChR2 but not in Chatcre mice. Representative trace (H) and mean HR (I) showing i.p. muscarinic parasympathetic blocker, methyl-scopolamine, eliminated the photostimulation-induced bradycardia, while sympathetic blockage with β−1 receptor blocker atenolol mildly reduced this bradycardia. Representative images of probe site (top) and immunohistochemical staining of NA showing c-Fos activation after stimulation of NA (J). Representative trace (K) and mean HR (L) showing the nicotinic antagonist, hexamethonium (i.p.) abolished photostimulation-induced bradycardia in both DMV and NA. Bars represent mean and SEM. Blue bars/shading indicates light stimulation. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
Figure 2:
Figure 2:
DMV innervates cardiac tissue through the vagus nerve in male mice. Schematic showing injection into the epicardial fat pad and labeling in both CVN brain regions (A). Representative images of DMV and NA after cardiac injection of retrograde tracers, rhodamine (left in red) and cholera toxin subunit B (CT-B; right in green) (B). Both rhodamine and CT-B significantly labeled cardiac projecting neurons in NA and DMV (C). Representative images of DMV after a right cervical vagotomy (C). Representative image (D) and mean cell count (E) showing a right cervical vagotomy significantly attenuated CVNDMV numbers ipsilateral to vagotomy. Bars represent mean and SEM. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
Figure 3:
Figure 3:
Differential electrophysiological properties of CVNDMV compared to CVNNA in male mice. Rhodamine-positive DMV neurons showing pipette (top) and rhodamine (bottom; red) (A). Representative immunofluorescence image of CVNDMV showing biocytin recovered patched cardiac-labeled neurons are cholinergic (B). Representative trace (C) and mean firing rate (D) of CVNDMV neurons show significantly higher spontaneous firing rates compared to CVNNA, with the majority of CVNDMV firing. No statistical differences in resting membrane potential were found between CVNDMV and CVNNA (E). Representative traces of membrane responses from CVNNA (top) and CVNDMV (bottom) to stepped current injections (F). Current-voltage (I-V) relationship graph obtained from CVNNA and CVNDMV (G). Rinput was higher in CVNDMV compared to CVNNA (H). Representative action potential responses in CVNNA (top) and CVNDMV (bottom) in response to 300 pA injection of direct depolarizing current (I). Action potential response curves were higher in CVNDMV compared to CVNNA in response to 50 pA-step injections of direct depolarizing current (J). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
Figure 4:
Figure 4:
Chemogenetic stimulation of DMV produces bradycardia and reduces anxiety in both male and female mice. Illustration of coronal hindbrain section showing injection site and Chat and Phox2b expression (A, top left); Schematic of AAV1-CreON/FlpON-hM3Dq-HA viral construct (A, bottom); Venn diagram showing expected expression of hM3Dq-HA and H2b-GFP (A, top right). Representative images of rostral, intermediate, caudal DMV and NA stained for HA (magenta) and H2b-GFP (green) immunoreactivity in ChatCre;Phox2bFlp;R26ds-HTB mice after DMV injection of AAV1-CreON/FlpON-hM3Dq-HA (B). Percentage of H2b-GFP+ cells immunoreactive for hM3Dq-HA in the rostral, intermediate and caudal DMV and NA (C). Effect of CNO on HR in DMV-hM3Dq mice over 24-hour period. CNO (1mg/kg, i.p.) injected at time = 0 min (D). Effect of i.p. saline, CNO and CNO+MA on HR in DMV-hM3Dq (magenta) and control mice (black); comparisons are to baseline (E). Schematic of open field experiment (F). Effects of i.p. saline vehicle and CNO on time in the center of the open field, in seconds (G). Correlation between changes in HR and center time between saline and CNO conditions in DMV-hM3Dq mice (H).Schematic of elevated plus maze (EPM) experiment (I). Effects of i.p. saline vehicle, CNO and CNO+MA administration on time spent moving in the elevated plus maze, in seconds (J). Effect of i.p. saline vehicle, CNO and CNO+MA administration on open-arm time in the elevated plus maze, in seconds (K). Effect of i.p. saline vehicle, CNO and CNO+AQ administration on open-arm time in the elevated plus maze, in seconds. (L). Correlation between changes in HR and open-arm time between saline and CNO conditions in DMV-hM3Dq mice (M). Effects of i.p. MA and AQ-RA-741 on open-arm time in elevated plus maze, compared to saline; same saline, CNO, and CNO+MA data as in Figure 4K (N). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.

Publication types